{"id":36631,"date":"2026-07-22T11:16:36","date_gmt":"2026-07-22T11:16:36","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=36631"},"modified":"2026-07-22T11:16:36","modified_gmt":"2026-07-22T11:16:36","slug":"restore-vision-and-forge-biologics-accelerate-gene-therapy","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/","title":{"rendered":"\u300cRestore Vision\u300d\u3068\u300cForge Biologics\u300d\u304c\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u52a0\u901f"},"content":{"rendered":"

Restore Vision kind of has signed a development and manufacturing agreement with Forge Biologics to back RV-001, its experimental gene therapy for retinitis pigmentosa, and it is already now in Phase 1\/2 trial testing in Japan.<\/p>\n

In the deal Forge will handle process development, cGMP manufacturing, analytical testing, stability studies and regulatory support, so things move along without too much delay. The therapy will be produced at Forge\u2019s facility in Columbus, Ohio, before trial material is shipped to Japan.<\/p>\n

RV-001 is an AAV-based optogenetic gene therapy being developed for people with retinitis pigmentosa. The agreement gives Restore Vision<\/a> access to manufacturing capacity and regulatory support as the program moves through early-stage clinical testing.<\/p>\n

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a \u65e5\u672c\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30fb\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306f\u3001AI\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u3001\u30c7\u30b8\u30bf\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a9\u30fc\u30e1\u30fc\u30b7\u30e7\u30f3\u3092\u878d\u5408\u3055\u305b\u3001\u672a\u6765\u306e\u7523\u696d\u3092\u5f62\u4f5c\u3063\u3066\u3044\u307e\u3059\u3002<\/a><\/h4>\n

\u306b\u3064\u3044\u3066 Forge<\/a>, the partnership adds another clinical-stage gene therapy program to its pipeline of manufacturing work and expands its reach with developers running trials in the Asia-Pacific region. The company already supports a range of gene therapy programs, and this latest deal adds to that effort.<\/p>","protected":false},"excerpt":{"rendered":"

Restore Vision kind of has signed a development and manufacturing agreement with Forge Biologics to back RV-001, its experimental gene therapy for retinitis pigmentosa, and it is already now in Phase 1\/2 trial testing in Japan. In the deal Forge will handle process development, cGMP manufacturing, analytical testing, stability studies and regulatory support, so things move along without too much delay. The therapy will be produced at Forge\u2019s facility in Columbus, Ohio, before trial material is shipped to Japan. RV-001 is an AAV-based optogenetic gene therapy being developed for people with retinitis pigmentosa. The agreement gives Restore Vision access to manufacturing capacity and regulatory support as the program moves through […]<\/p>\n","protected":false},"author":7,"featured_media":36632,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[181,89,207,237],"tags":[150,14199,11744,575,14198],"ppma_author":[572],"class_list":["post-36631","post","type-post","status-publish","format-standard","has-post-thumbnail","category-biotech","category-health-tech","category-international","category-news","tag-biotech","tag-forge-biologics","tag-gene-therapy","tag-pharmaceutical","tag-restore-vision"],"yoast_head":"\nRestore Vision Expands Gene Therapy Development<\/title>\n<meta name=\"description\" content=\"Forge Biologics will support Restore Vision with end-to-end AAV development and cGMP manufacturing for ophthalmic gene therapy programs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Restore Vision Expands Gene Therapy Development\" \/>\n<meta property=\"og:description\" content=\"Forge Biologics will support Restore Vision with end-to-end AAV development and cGMP manufacturing for ophthalmic gene therapy programs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-22T11:16:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/07\/Restore-Vision-and-Forge-Biologics-Announce-AAV-Development-and-cGMP-Manufacturing-Partnership.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Restore Vision Expands Gene Therapy Development","description":"Forge Biologics will support Restore Vision with end-to-end AAV development and cGMP manufacturing for ophthalmic gene therapy programs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/","og_locale":"ja_JP","og_type":"article","og_title":"Restore Vision Expands Gene Therapy Development","og_description":"Forge Biologics will support Restore Vision with end-to-end AAV development and cGMP manufacturing for ophthalmic gene therapy programs.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/","og_site_name":"itbusinesstoday","article_published_time":"2026-07-22T11:16:36+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/07\/Restore-Vision-and-Forge-Biologics-Announce-AAV-Development-and-cGMP-Manufacturing-Partnership.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Restore Vision and Forge Biologics Accelerate Gene Therapy","datePublished":"2026-07-22T11:16:36+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/"},"wordCount":183,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/07\/Restore-Vision-and-Forge-Biologics-Announce-AAV-Development-and-cGMP-Manufacturing-Partnership.webp","keywords":["Biotech","Forge Biologics","gene therapy","pharmaceutical","Restore Vision"],"articleSection":["Biotech","Health Tech","International","News"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/","name":"Restore Vision Expands Gene Therapy Development","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/07\/Restore-Vision-and-Forge-Biologics-Announce-AAV-Development-and-cGMP-Manufacturing-Partnership.webp","datePublished":"2026-07-22T11:16:36+00:00","description":"Forge Biologics will support Restore Vision with end-to-end AAV development and cGMP manufacturing for ophthalmic gene therapy programs.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/07\/Restore-Vision-and-Forge-Biologics-Announce-AAV-Development-and-cGMP-Manufacturing-Partnership.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/07\/Restore-Vision-and-Forge-Biologics-Announce-AAV-Development-and-cGMP-Manufacturing-Partnership.webp","width":1200,"height":800,"caption":"Restore Vision"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/restore-vision-and-forge-biologics-accelerate-gene-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Restore Vision and Forge Biologics Accelerate Gene Therapy"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/36631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=36631"}],"version-history":[{"count":3,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/36631\/revisions"}],"predecessor-version":[{"id":36635,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/36631\/revisions\/36635"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/36632"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=36631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=36631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=36631"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=36631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}